Sequential measurements of cardiac output, intravascular pressures, blood gases, pH, blood volume, and oxygen consumption were made in normal subjects and patients in shock before, during, and after infusions of dextran-40. In eight normal subjects the responses were: increased central venous pressure, increased cardiac index, decreased peripheral resistance, and decreased hemoglobin concentrations. These changes were of short duration and were attributed largely to increased plasma volume from the infusion.
T X HE PHYSIOLOGICAL ACTION of dextran-40 may depend solely on its capacity to expand plasma volume; alternatively, this agent may have significant clinical effects by its action on the microcirculation. Expansion of plasma volume in excess of the vol- observed with whole blood or saline.4 However, in hemorrhagic shock, dextran-40 and whole blood transfusion were equally effective in restoring cardiac output and other hemodynamic measurements to normal values.5 Gelin6 7observed stasis of red cells and cellular aggregation in low flow states and following tissue injury in experimental animals and man. Intravascular aggregation was produced by the injection of thrombin or high molecular weight dextran; the process was reversed with dextrans of low molecular weight.8 Dextran-40 has been shown to improve capillary blood flow,6' 7 reverse cellular aggregation,9 and draw back into the circulation cells which have been trapped in the microcirculation. 10 The decrease in viscosity attributed to dextran-40 was related to the degree of hemodilution and the associated fall in hematocrit and protein concentrations.", 12 Lofstrom13 observed a fall in oxygen consumption associated with intravascular aggregation after infusion of high molecular weight dextran in rabbits. By contrast, rapid disappearance of cellular aggregation and increased oxygen consumption followed infusion of dextran-40. 13 Increased oxygen. consumption and partial hemodynamic recovery were also observed in dogs subjected to hemorrhagic shock. '4 The present study was undertaken to inquire more specifically into the hemodynamic mechanisms and oxygen transport patterns involved in the dextran response in normal subjects and patients in shock. Sequential hemodynamic and blood volume measurements were taken after each 100 ml during the dextran infusion and at regular intervals after infusion. Simultaneous measurements of blood gases and pH were obtained in most of the patients and calculation of arteriovenous (A-V) oxygen content differences, oxygen extraction ratio, and oxygen consumption were made.
Materials and Methods

Clinical Material
Eight healthy volunteer subjects and 26 patients Circulation, Volume XXXIX, March 1969 in shock from the surgical services and trauma unit of Cook County Hospital were studied. Mean arterial blood pressures averaged 42 mm Hg at the time of most profound shock and 57 mm Hg at the onset of dextran infusion. In addition to hypotension the patients also demonstrated other clinical evidence of shock such as tachycardia, narrow pulse pressure, oliguria, cyanosis, and tachypnea. Various etiological factors were responsible for the state of circulatory failure in these patients including hemorrhage, dehydration, trauma, sepsis, or a combination of these factors. The clinical data are summarized in table I. The data from the shock patients were compared with data obtained in eight healthy young adults who were awaiting minor elective surgical procedures. The shock patients were divided into two groups on the basis of their cardiac output response to dextran-40. Group I patients had a sustained increase in cardiac output of 25% or more after the infusion, which was considered an appreciable response; group II patients had less than 25% increase in cardiac output after dextran infusion.
Methods
Catheters were inserted into the superior vena cava or right atrium by percutaneous puncture of the basilic or subclavian vein. A plastic catheter also was inserted through a modified Cournand needle introduced percutaneously into the femoral artery. Central venous pressure and arterial pressures were measured with Statham pressure transducers and recorded on an Offner multiple channel recorder.
Cardiac output was calculated from indicatordilution curves according to the Stewart-Hamilton method.2 15 A known amount of indocyaninegreen dye was injected rapidly through the central venous pressure catheter. Samples of arterial blood were obtained with a constant withdrawal syringe; concentrations of dye were measured and calibrated by using a Gilford photodensitometer. Cardiac ouptut and mean transit times were calculated from the dye curves by a Raytheon 440 computer programmed for this purpose. Central blood volume, total peripheral resistance, stroke volume, and left ventricular stroke work were derived from standard formulas. For comparative purposes these are expressed in terms of surface area.
Plasma volume was measured by using '31Ilabeled human serum albumin (RHISA). After three control blood samples were drawn, an aliquot of RHISA was injected. Five or six blood samples were collected at intervals and the plasma radioactivity was measured in a well-type scintillation counter. Plasma volume was calculated from the semi-logarithmic plot of these data against time. Blood samples were collected from 18 patients at 10-minute intervals for the calculation of plasma volume changes during and after the infusion of dextran-40 using a modification16 of the method of Gelin and associates.'
In 22 patients arterial and mixed venous samples for blood gas analysis were obtained simultaneously with the hemodynamic measurements. Arterial and mixed venous P02, PCO2, and pH were measured with an Instrumentation Laboratory blood gas-pH meter. Hemoglobin concentration was determined spectrophotometrically. Oxygen saturation and oxygen content were calculated from these values by utilizing standard nomograms and formulas.'7 Oxygen consumption was calculated by multiplying the A-V 02 difference by the cardiac index. Previously, comparison was made of oxygen consumption data calculated as the product of cardiac output and A-V oxygen difference, with use of direct measurements in controlled animal experi-ments18 and with use of the Douglas bag for collection of expired air in studies of patients.'9 While the patient breathed room air, the expired air was collected in a Douglas bag for 3 min; a carefully fitted mouthpiece was used and the nasal orifices were completely occluded. During the last minute of the collection of expired air, cardiac output was measured by the indicatordilution method. Arterial and mixed venous blood were sampled simultaneously and analyzed for oxygen content. Simultaneous measurements of oxygen consumption by the two methods varied from 7 to 21%; the average difference was 11%. 19 In general, the results of the method for calculating oxygen consumption by A-V oxygen content differences multiplied by cardiac index in both clinical and experimental conditions were self-consistent and differed from the direct Fick method in a systematic way. Thus, data indicating changes in oxygen consumption were more reliable than the absolute derived values.
The oxygen extraction ratio was calculated according to the formula:
CaO2 where CaO2 and CvO2 are the arterial and venous oxygen contents, respectively.
Protocol
After three to seven control hemodvnamic measurements, 500 ml of dextran-40 was infused over a period of 60 min at the rate of 100 ml every 10 min. Measurements were made after each 100 ml was infused, and were continued at intervals for 2 to 3 hours after infusion. 
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Results
Hemodynamic Responses
Control Subjects
The data describing hemodynamic responses to 500 ml of dextran-40 infusion into control subjects are summarized in table 2. There were increased cardiac index, stroke index, central venous pressure, and stroke work, and reduced total peripheral resistance after dextran administration. No significant alterations were noted in heart rate, mean arterial blood pressure, or mean transit time; transient elevations of central blood volume occurred. The sequence of these changes is illustrated in figures 1 and 2. The first observable effect was increased central venous pressure, which reached maximal values after 500 ml of dextran-40 was infused. This was followed by an increase in cardiac index, stroke index and stroke work, and a reduction of total peripheral resistance. These Sequential changes in cardiovascular measurements before, during, and after dextran-40 administration in normal subjects (dotted line) and in group I shock patients (solid lines).
gradually returned to pre-infusion values at the end of 2 hours.
Shock Patients
Group I Patients. Nineteen of the shock patients demonstrated increased cardiac outputs after infusion of dextran-40. The hemodynamic data from these patients are presented in table 3 and illustrated in figures 1 and 2. All except three patients had normal or low cardiac outputs and central venous pressures during the control period. Associated with the improved cardiac outputs were elevation of stroke index, central venous pressure, central blood volume, and stroke work, and reduction of total peripheral resistances and mean transit time.
Mean arterial blood pressure improved, but reached normal levels in only 10 patients. were more pronounced and remained above control levels 2 to 3 hours after infusion. In essence, the sequence of hemodynamic events was similar to that observed in the control patients, except that in the group I patients, maximal responses occurred 20 to 40 minutes later. Group II Patients. Seven of the 26 shock patients (table 4) showed little or no hemodynamic improvement after the infusion of dextran-40. In the control period, one patient had a high cardiac output; the remainder had cardiac outputs in the normal or below normal range. Central venous pressures varied from low to high normal levels. After dextran infusion there was essentially no change in cardiac index, stroke index, mean blood pressure, heart rate, stroke work, mean transit time, or central blood volume. Minimal reductions occurred in total peripheral resistance. Central venous pressures remained markedly elevated 1 hour after infusion of dextran-40.
Blood Volume Control Subjects
Plasma volume expansion paralleled the changes in cardiac index and central venous pressure, and was in the opposite direction to changes in total peripheral resistance. Maximal volume expansion occurred at the end of the 400-ml infusion. The average change for the group was 630 ml, an increase of 19% above control values. The average hematocrit fell from 40% to 34%. At the end of 2 hours plasma volume was nearly at the preinfusion level.
Shock Patients
Blood volumes measured before dextran infusion indicated that nine of the 26 shock patients were hypovolemic. Control blood volumes ranged from deficits of 1,900 ml to excesses of 2,000 ml; the average blood volume was 680 ml less than that predicted from standard values based on surface area. Control hematocrit values ranged from 21% to 50% and averaged 34% for the group. The maximal plasma volume increase occurred approximately 15 minutes after the end of the infusion, this averaged 735 ml or 28% increase above control values. Hematocrits declined from 34% to 27%. The degree of deficit or excess in control measurements of blood volume did not correlate well with the changes in blood volume or cardiac output induced by dextran-40. Similarly, no relationship was seen between control hematocrit values and the cardiac output response to dextran. At the end of 2 hours, plasma volume was still significantly above control levels. As with the control subjects, the plasma volume expansion occurred simultaneously with the hemodynamic changes. There were essentially no differences in plasma volume expansion between group I and group II patients.
Blood Gas, pH, and Oxygen Metabolism Control Subjects
No significant changes were observed in oxygen extraction ratios, P02, 02 saturation, pCO2, pH, and oxygen consumption values. The hemodynamic changes were accompanied by slightly decreased hemoglobin concentrations, arterial and venous oxygen contents, and A-V oxygen differences. The last were entirely explicable in terms of modest plasma volume expansion with associated reductions in hematrocrit values.
Shock Patients
Group I. Oxygen consumption (V02) was calculated in 11 patients who responded with an increase in cardiac output during the infusion of dextran-40 (tables 5 and 6). In this group, five patients had increased V02, and six patients had no significant change in V02. Generally, the patients who responded to dextran infusion with increased VO2 had lower control V02, hematocrit, pH, and CaO2, but higher arterial P02 than did the patients* who failed to have increased V02. There were essentially no differences between the two groups in terms of the other parameters measured. Accompanying the improvement in V02, the arterial and venous pH values gradually increased in two patients who were moderately acidotic during the control period. Arterial and venous 02 contents 7) had the lowest venous oxygen contents and the highest oxygen extraction ratios of the entire shock group. The other parameters measured were similar to the other shock patients. Slightly decreased VO2 and pH values as well as increased 02 extraction, which were not significant, were observed at the end of infusion. Essentially no change in arterial or venous PO2 or pCO2 was noted. As in the other groups, 02 contents and hemoglobin concentrations decreased.
Discussion
Our data tend to substantiate the concept that the hemodynamic responses to dextran-40 infusion in normal subjects are primarily attributable to plasma volume expansion. However, in the shock patients, there was a greater degree of plasma volume expansion as well as greater and more prolonged hemodynamic effects after dextran administration. In 73% of the shock patients, dextran infusion increased cardiac output 50% or more. The latter change was preceded by increased central venous pressure and central blood volume as well as by reduction in total peripheral resistance and mean transit time. Previous work demonstrated improved flow at the microcirculatory level after dextran-40.8-10 The data of our study are consistent Circulation, Volume XXXIX, March 1969 with the concept that hemodynamic effects of dextran-40 in shock patients result from improvement in small vessel flow as well as increased blood volume and hemodilution. Increased central blood volume as well as increased central venous pressure in the face of increased cardiac output suggests that in addition to increased blood volume there is redistribution of blood volume from the microcirculation into the central circulation.
After dextran infusion, moderately increased left ventricular stroke work occurred with increased cardiac index and central venous pressure. Left ventricular stroke work approached pre-infusion levels 1 hour after the end of dextran infusion ( fig. 3 ), but the cardiac index remained significantly elevated for 2 hours after the end of the infusion. There were proportionally greater increases in blood flow than in arterial pressure; cardiac index exceeded normal values, while cardiac work remained significantly below normal values throughout the course of dextran therapy. Obviously, lesser degrees of cardiac work are required in the face of lowered peripheral resistance. It has been shown that changes in myocardial oxygen consumption are lesser in magnitude when changes in cardiac work result from increased flow as opposed to increased pressure.20 This effect is probably desirable from a therapeutic point of view.
The oxygen consumption changes observed in the shock patients after dextran may be related to the etiological factors contributing to their circulatory failure. In the patients who had increased oxygen consumption during dextran-40 infusion (group IA) hemorrhage and trauma usually were the etiological agents of shock. By contrast, the patients in group II with one exception had sepsis as The cardiac function curve in group I shock patients (center curve) shifted downward but was parallel to that of the normal subjects. Increased central venous pressures were associated with marked improvement in left ventricular stroke work. Two hours following dextran, both of these returned toward, but did not reach, control values.
Group II patients (lower, right-hand curve) had a rather flat cardiac function curve which was shifted downward and to the right. After dextran infusion, left ventricular stroke work deteriorated while central venous pressure remained high. patients indicate that the lung adequately oxygenated venous blood and the blood had adequate oxygen-carrying capacity. But increased oxygen consumption after dextran suggests that oxygen transport had not been adequate to meet the increased needs of the disturbed circulatory state. Previously, we have observed increased oxygen consumption rates in hemorrhagic shock after transfusion.'4 If tissue oxygenation were less than optimal, increased tissue perfusion would be expected to increase oxygen utilization.
In the group IB patients who predominantly had septic processes, cardiac output increased to the same extent as in group IA, but the percentage of oxygen extraction decreased and there was no change in the rate of oxygen consumption after dextran administration. In the pre-infusion control period, these patients had the highest average control oxygen consumption rates of all of the shock groups, the lowest venous oxygen saturations, and the greatest A-V oxygen differences. The high pre-infusion oxygen consumption and the lack of increase after dextran may indicate that either these patients did not have limited oxygen transport or dextran did not improve oxygen transport. Thus, the observed hemodynamic changes in this group of shock patients were largely attributable to hemodilution and plasma volume expansion.
Group II patients had higher cardiac outputs, arterial pressures, and venous pressures in the pre-infusion control period than did group I patients. During infusion of dextran-40, cardiac output remained essentially unchanged; increased central venous pressure was the only striking and statistically significant hemodynamic alteration in this group. These patients showed no evidence of myocardial failure prior to receiving dextran-40; central venous pressures, although within the normal range, tended to be higher than in the other groups. Previous studies showed that shock patients who failed to respond to the volume load improved markedly with isoproterenol infusion suggesting the presence of limited myocardial function. 21 The average oxygen consumption for group II patients in the pre-infusion period was greater than that of the normal subjects. Although arterial oxygen saturation and contents were near normal levels, these patients had rather pronounced degrees of venous desaturation, high oxygen extraction ratios, and Wide A-V oxygen differences. The tissues of these patients were already working at Circulation, Volume XXXIX, Marcb 1969 
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high rates of oxygen extraction and utilization. This suggests that the capacity of the tissues to remove oxygen was not impaired, despite the hypotension.
